These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 34764391)
1. Exposing structural variations in SARS-CoV-2 evolution. Yang J; Zhang P; Cheng WX; Lu Y; Gang W; Ren G Sci Rep; 2021 Nov; 11(1):22042. PubMed ID: 34764391 [TBL] [Abstract][Full Text] [Related]
2. Exposing Structural Variations in SARS-CoV-2 Evolution. Yang J; Zhang P; Cheng WX; Lu Y; Gang W; Ren G Res Sq; 2021 Sep; ():. PubMed ID: 34545355 [TBL] [Abstract][Full Text] [Related]
3. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2. Hatmal MM; Alshaer W; Al-Hatamleh MAI; Hatmal M; Smadi O; Taha MO; Oweida AJ; Boer JC; Mohamud R; Plebanski M Cells; 2020 Dec; 9(12):. PubMed ID: 33302501 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Zahradník J; Marciano S; Shemesh M; Zoler E; Harari D; Chiaravalli J; Meyer B; Rudich Y; Li C; Marton I; Dym O; Elad N; Lewis MG; Andersen H; Gagne M; Seder RA; Douek DC; Schreiber G Nat Microbiol; 2021 Sep; 6(9):1188-1198. PubMed ID: 34400835 [TBL] [Abstract][Full Text] [Related]
6. Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach. Lokman SM; Rasheduzzaman M; Salauddin A; Barua R; Tanzina AY; Rumi MH; Hossain MI; Siddiki AMAMZ; Mannan A; Hasan MM Infect Genet Evol; 2020 Oct; 84():104389. PubMed ID: 32502733 [TBL] [Abstract][Full Text] [Related]
7. Mutations Strengthened SARS-CoV-2 Infectivity. Chen J; Wang R; Wang M; Wei GW J Mol Biol; 2020 Sep; 432(19):5212-5226. PubMed ID: 32710986 [TBL] [Abstract][Full Text] [Related]
8. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA Elife; 2021 Aug; 10():. PubMed ID: 34435953 [TBL] [Abstract][Full Text] [Related]
9. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein. Behloul N; Baha S; Shi R; Meng J Virus Res; 2020 Sep; 286():198058. PubMed ID: 32531235 [TBL] [Abstract][Full Text] [Related]
10. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern. Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802 [TBL] [Abstract][Full Text] [Related]